Related Experiment Video
Updated: Oct 20, 2025

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
Published on: March 17, 2016
Non-genomic signaling of steroid receptors in cancer
Charlène Thiebaut1, Virginie Vlaeminck-Guillem2, Olivier Trédan3
1Université de Lyon, F-69000, Lyon, France; Inserm U1052, Centre de Recherche en Cancérologie de Lyon, F-69000, Lyon, France; CNRS UMR5286, Centre de Recherche en Cancérologie de Lyon, F-69000, Lyon, France.
Abstract:
Steroid receptors (SRs) are members of the nuclear receptor family, which are ligand-activated transcription factors. SRs regulate many physiological functions including development and reproduction, though they can also be involved in several pathologies, especially cancer. Highly controlled cellular responses to steroids involve transcriptional regulation (genomic activity) combined with direct activation of signaling cascades (non-genomic activity). Non-genomic signaling has been extensively studied in cancer, mainly in breast cancer for ER and PR, and prostate cancer for AR. Even though most of the studies have been conducted in cells, some of them have been confirmed in vivo, highlighting the relevance of this pathway in cancer. This review provides an overview of the current and emerging knowledge on non-genomic signaling with a focus on breast and prostate cancers and its clinical relevance. A thorough understanding of ER, PR, AR and GR non-genomic pathways may open new perspectives for the development of therapeutic strategies.
Insights
Steroid receptors (SRs) control cellular functions and cancer. This review details non-genomic signaling pathways of SRs in breast and prostate cancers, offering insights for new therapeutic strategies.
Area of Science:
- Molecular Biology
- Endocrinology
- Oncology
Background:
- Steroid receptors (SRs) are nuclear receptors regulating physiological functions and pathologies like cancer.
- Cellular responses to steroids involve genomic and non-genomic activities.
- Non-genomic signaling is crucial in breast (ER, PR) and prostate (AR) cancers.
Purpose of the Study:
- To review current and emerging knowledge on non-genomic SR signaling.
- To focus on breast and prostate cancers and their clinical relevance.
- To explore potential therapeutic strategies based on non-genomic pathways.
Main Methods:
- Literature review of studies on non-genomic steroid receptor signaling.
- Focus on in vitro and in vivo evidence.
- Analysis of clinical relevance in breast and prostate cancers.
Main Results:
- Non-genomic signaling plays a significant role in cancer development and progression.
- Specific SRs (ER, PR, AR) exhibit distinct non-genomic activities in relevant cancers.
- Studies confirm the relevance of these pathways both in vitro and in vivo.
Conclusions:
- Understanding non-genomic SR pathways is vital for cancer research.
- Targeting non-genomic signaling offers novel therapeutic opportunities.
- Further research into ER, PR, AR, and GR non-genomic pathways may lead to improved cancer treatments.
More Related Videos
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Signal Transduction: Overview
Typically, signal transduction involves three...
Internal Receptors
Chemical Signaling in the Endocrine System
Lipid-soluble hormones, such as steroid hormones, demonstrate an intracellular action. These hormones traverse cell membranes due to their lipid nature. Once inside the target cell, they...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Autocrine Signaling
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...

